CAS Number 56290-94-9 ChemSpider 38173 Formula C20H24N2O5 Molar mass 372.415 g/mol | PubChem CID 41835 ECHA InfoCard 100.054.618 3D model (Jmol) Interactive image | |
How to pronounce medroxalol
Medroxalol is a vasodilator beta blocker also classified as a mixed receptor blocker as it blocks both alpha and beta receptors.
Contents
Synthesis
For the first step, salicylamide (1) is the subject of a Friedel-Crafts acetylation and then the aromatic methylketone is halogenated. in the usual manner. The bromide in 2 is then displaced by the nitrogen in N-benzyl-1-(3',4'-methylenedioxyphenyl)-3-butylamine (3), which is itself prepared by reductive amination on the corresponding ketone. The product of the last step (4) is catalytically hydrogenated. This serves the dual purpose both of reducing the ketone and removing the benzyl protecting group affording the product medroxalol (5). Note that a benzyl protecting group is not necessarily used.
References
Medroxalol Wikipedia(Text) CC BY-SA